Allurion Literature – May 2025 Allurion Literature – Journal Publications (23) ABSTRACTS Meta - Analyses and Registry Studies (1/2) 3 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • • • • • • • • • • • • • • • • • • • • • Meta - Analyses and Registry Studies (2/2) 4 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • ² • • • • ² • • • • • • • • • • • • • • • • • • • • • Safety and efficacy data from around the world - LATAM 5 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • ± • • ± • ± ² • • • • • • • • • ² • • • • ² • • • • • • Safety and efficacy data from around the world – MEA (1/2) 6 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • ² • • ± • • ± ² • ± • ± • ± ² • ± • • • • • • • ² • • • • • ² • o o o • • • • Safety and efficacy data from around the world – MEA (2/2) 7 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • ² • • • • • • • • • • • • • ² • • • • • • ² • • • • • • • • Safety and efficacy data from around the world – Europe (1/3) 8 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • ² • • • • • • ² • • • • • • • ² • • • • • • ± • ± • ± ² • ± • • • ² • ± • • • Safety and efficacy data from around the world – Europe (2/3) 9 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • ² • • • • • • ² • ² • • • • • • • • • ² ² • • • • • • • Safety and efficacy data from around the world – Europe (3/3) 10 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • ² • • • • • ² • • • • • • • • • • ² • • • • • ² • • • • • Safety and efficacy data from around the world – APAC 11 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • ² • • • • • • ² • ² • ² • • • • ± ² • ± ² • ± ² • • • • • • Adolescent patients 12 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • ² • • ² • • • • Body Composition Analysis 13 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • ² • ² • • • • • • Combination Therapy With Weight - Loss Drugs 14 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • ² • • • • • • • • Symptom Management 15 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • ² • • • • • • Cost - effectiveness of the Allurion Balloon 16 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • ² • • • • • • mHealth Coaching in Combination with the Allurion Balloon Program 17 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • ² • • • • • ² • • • • • • • Allurion Literature – Abstracts (35) MANUSCRIPTS Multicenter Studies Demonstrating Safety & Efficacy 19 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • • ² • ² • • • • • • • • • • • ² • ² • • • • • • • • • • • ² • • ² • • • • • Single - Center Study Demonstrating Safety & Efficacy 20 © 2022 ALLURION TECHNOLOGIES - PROPRIETARY INFORMATION – CONFIDENTIAL • • • • • • ± ± • • • • • • •